Health & Biotech ASX Health Stocks: ResApp skyrockets 25% after getting buyout offer from US giant Pfizer April 11, 2022 ResApp gets takeover offer from Pfizer Recce gets Hong Kong patent RhinoMed comes out of trading halt and rallied 20%… Dr Boreham’s Crucible: Putting Microba under the microscope April 8, 2022 It’s easy to get the impression that the bloke upstairs is trying to knock us all off - one way… Bring it on: PharmAust to start Phase 1 trial after first instalment lands from FightMND April 8, 2022 Special Report: The much anticipated Phase 1 clinical trial of PharmAust’s lead asset monepantel on patients with Motor Neurone Disease… ASX Health Stocks: Pro Medicus bags $32m deal, Kazia shows promise in child cancer drug April 8, 2022 Pro Medicus signs $32m deal in the US Kazia shows promise with lead drug paxalisib in child cancer Pro Medicus signs… Osteopore makes first shipment to Colombia, the first of many Latin American markets it will pursue April 8, 2022 Special Report: Osteopore’s shipment to Colombia is part of the company’s strategy to penetrate new global markets. Weed Week: Will the US Senate pass the MORE act, and Swiss cannabis wellness spas are a thing April 8, 2022 Avecho flags positive results from the Phase IIa study of its CBD topical gel for arthritis and Cann to commercialise… Strong Q3 revenue for Wellnex Life with impressive pipeline of new brands and products ahead April 7, 2022 Special Report: Wellnex Life experiences another quarter of strong revenue growth with strong organic growth across brands and several major… ASX Health Stocks: AdAlta gets patent in India, RhinoMed starts selling in Canada April 7, 2022 AdAlta gets first patent in India RhinoMed to start selling Covid swaps and RAT kits in Canada AdAlta (ASX:1AD) has… ASX Health Stocks: Cann to market over-the-counter CBD capsules in Australia April 6, 2022 Cann will market its CBD capsules in Australia 4DMedical's XV LVAS software is being trialed in a hospital in California… Medlab Clinical looks to revolutionise drug delivery for better patient outcomes April 6, 2022 Special Report: Medlab’s focus on improving patient outcomes is leading to a homegrown revolution in the way drug medications are… Next» « Previous